Inhalation Sciences (ISAB) has announced that a "noted global pharma company" has placed an order worth €75,000 for a contract research project utilizing ISAB's DissolvIt system. The DissolvIt module is used to simulate dissolution and absorption of dry powder formulations in the lung and generates data including Cmax and Tmax curves. ISAB CEO Manoush Masarrat … [Read more...] about Inhalation Sciences announces new agreement for project using DissolvIt lung simulation tool
Products and Services
Respira Technologies launches RespiRx nebulizer platform
Vaping startup Respira Technologies has announced the launch of its RespiRx delivery device platform, which the company is aiming at pharmaceutical drug delivery "across the fullest spectrum of pressure and thermo sensitive APIs." The company, which has backing from several venture capital companies, says that it is now a "a platform device and biotechnology company … [Read more...] about Respira Technologies launches RespiRx nebulizer platform
Iconovo’s ICOcap DPI gets CE mark for clinical trial use
DPI developer Iconovo announced that the company's ICOcap capsule-based dry powder inhaler ICOcap is now CE marked for use in clinical trials. The ICOcap inhaler is available from the Stevanato Group, which signed a manufacturing, sales, and distribution agreement for the inhaler with Iconovo in 2018. Iconovo CEO Johan Wäborg commented, "Getting the CE … [Read more...] about Iconovo’s ICOcap DPI gets CE mark for clinical trial use
Propeller Health sensor for Symbicort gets 510(k) clearance
Propeller Health announced that the FDA has granted 510(k) clearance for the company's inhaler monitoring sensor for AstraZeneca's Symbicort MDI. The Propeller sensor snaps on to the inhaler and connects via Bluetooth to a mobile app. The company also manufactures sensors for MDIs, DPIs, and SMIs made by GSK, Novartis, Orion, and Boehringer Ingelheim. Propeller … [Read more...] about Propeller Health sensor for Symbicort gets 510(k) clearance
iCAIR consortium initiates project to develop inhaled drugs for COVID-19
A consortium called Fraunhofer International Consortium for Anti-Infective Research (iCAIR) -- composed of researchers from Fraunhofer ITEM, Griffith University, Hannover Medical School, and Twincore -- has announced that it has initiated a project to develop inhaled drugs to treat COVID-19, starting with high-throughput screening for candidates by temporary … [Read more...] about iCAIR consortium initiates project to develop inhaled drugs for COVID-19
Proveris Scientific now offering cGMP compliant laboratory services for OINDPs
Spray characterization specialist Proveris Scientific has announced that it is now offering contract testing services for OINDP regulatory submissions, release testing and stability studies, as well as for development projects. The company received ISO 9001:2015 certification in 2018, and the laboratory now also meets cGMP requirements for both the FDA and the … [Read more...] about Proveris Scientific now offering cGMP compliant laboratory services for OINDPs
Nanoform gets GMP certification
The Finnish Medicines Agency has granted GMP certification to nanonization specialist Nanoform Finland, the company said. In December 2019, Nanoform announced that it had applied for the certification. The company's CESS (controlled expansion of supercritical solutions) nanoparticle engineering platform will now be available for manufacturing of clinical trial … [Read more...] about Nanoform gets GMP certification
3M Drug Delivery Systems becomes Kindeva Drug Delivery
3M announced that it has completed the sale of "substantially all" of 3M Drug Delivery Systems to Altaris Capital Partners, and the new company is now known as Kindeva Drug Delivery. The initial announcement of the sale was made in December 2019. Kindeva issued a separate press release announcing its launch as "a leading global contract development and … [Read more...] about 3M Drug Delivery Systems becomes Kindeva Drug Delivery
Fluidda study suggests that inhaled vasodilators may be helpful in COVID-19
Functional respiratory imaging (FRI) company Fluidda has announced that an FRI study of COVID-19 patients has shown that the virus is resulting in narrowing of small capillaries in the lung, resulting in higher flow pressures that in turn causes higher pressure in the main blood vessels and suggests that vasodilators delivered to the lung may be a useful therapy. … [Read more...] about Fluidda study suggests that inhaled vasodilators may be helpful in COVID-19
Monaghan Medical will market Adherium’s Hailie inhaler monitoring platform in the US
Following the signing of a letter of intent for a sales agreement with Adherium, Monaghan Medical said that it will launch Adherium’s Hailie digital inhaler monitoring platform in the US. The Hailie sensor was approved by the FDA for US over the counter sales in July 2018, and Adherium launched the sensor in August of that year. Monaghan's parent company, Trudell … [Read more...] about Monaghan Medical will market Adherium’s Hailie inhaler monitoring platform in the US